Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;314(2):e241673.
doi: 10.1148/radiol.241673.

Disparities in Standard-of-Care, Advanced, and Same-Day Diagnostic Services among Patients with Abnormal Screening Mammography

Affiliations

Disparities in Standard-of-Care, Advanced, and Same-Day Diagnostic Services among Patients with Abnormal Screening Mammography

Marissa B Lawson et al. Radiology. 2025 Feb.

Abstract

Background Diagnostic imaging and biopsy are used to evaluate abnormal screening mammography. Differences in on-site availability and receipt of these diagnostic services may contribute to disparities in breast cancer outcomes across sociodemographic groups. Purpose To identify multilevel factors associated with on-site availability and receipt of diagnostic imaging and biopsy after screening mammography. Materials and Methods This retrospective study included female patients (age range, 40-89 years) who underwent screening mammography at 136 facilities in the United States from January 2010 to December 2020. The primary exposure variables were race and ethnicity and neighborhood-level educational attainment, household income, and rurality. The adjustment variables were age, breast density, breast biopsy history, personal and family history of breast cancer, time from prior mammographic examination to screening mammography, screening modality, facility academic affiliation, and screening examination year. The relative risk (RR) of factors for on-site availability at screening facilities and undergoing standard-of-care imaging (ie, mammography and/or US) and advanced diagnostic imaging (ie, digital breast tomosynthesis, MRI) and biopsy, and undergoing any same-day diagnostic service and biopsy were estimated using modified Poisson regression. Results In total, 1 123 177 female patients (median age, 59 years; IQR, 51-67 years) underwent 3 519 502 screening mammographic examinations: 10.3% Asian patients (362 440 of 3 519 502), 12.7% Black patients (447 777 of 3 519 502), 6.5% Hispanic patients (227 177 of 3 519 502), 68.3% White patients (2 403 159 of 3 519 502), and 2.2% all other races and ethnicities (78 949 of 3 519 502). In most fully adjusted models, race or ethnicity and neighborhood-level socioeconomic status were not associated with on-site diagnostic service availability. However, compared with White patients, patients belonging to racial and ethnic minority groups were less likely to undergo same-day diagnostic services after abnormal screening mammography (Asian patients: RR, 0.74 [95% CI: 0.64, 0.85]; Black patients: RR, 0.56 [95% CI: 0.49, 0.63]; Hispanic patients: RR, 0.61 [95% CI: 0.52, 0.71]). Black patients were less likely to undergo same-day biopsies after an abnormal diagnostic workup (RR, 0.46; 95% CI: 0.33, 0.65). Conclusion Although no evidence existed that on-site diagnostic service availability varied by race and ethnicity in most models, patients in racial and ethnic minority groups were less likely to be provided same-day diagnostic services and Black patients were less likely to undergo same-day biopsy. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Mullen in this issue.

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: M.B.L. Salary support paid to institution from GE HealthCare, Association of Academic Radiology; support for attending meetings and/or travel from GE HealthCare. W.Z. No relevant relationships. D.L.M. Grants to institution from American Cancer Society, PCORI; royalties from Elsevier. T.O. Funding to institution from National Cancer Institute. L.M.H. No relevant relationships. G.H.R. No relevant relationships. K.K. No relevant relationships. B.L.S. Grants to institution from American Cancer Society, American College of Radiology, PCORI. E.J.A.B. No relevant relationships. E.S.O. No relevant relationships. A.N.A.T. No relevant relationships. R.M.d.A. No relevant relationships. R.A.H. Grants to institution from FDA, VA, PCORI. J.M.L. Grant from GE HealthCare. C.I.L. Royalties from UpToDate, Oxford University Press, McGraw Hill; consulting fees from DeepHealth/RadNet; deputy editor, Journal of the American College of Radiology.

References

    1. Caswell-Jin JL , Sun LP , Munoz D , et al. . Analysis of Breast Cancer Mortality in the US-1975 to 2019 . JAMA 2024. ; 331 ( 3 ): 233 – 241 . - PMC - PubMed
    1. Hubbard RA , Zhu W , Horblyuk R , et al. . Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography . Breast Cancer Res Treat 2013. ; 138 ( 3 ): 879 – 887 . - PMC - PubMed
    1. Alsheik NH , Dabbous F , Pohlman SK , et al. . Comparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health System . Acad Radiol 2019. ; 26 ( 5 ): 597 – 605 . - PubMed
    1. Lee CI , Bogart A , Hubbard RA , et al. . Advanced Breast Imaging Availability by Screening Facility Characteristics . Acad Radiol 2015. ; 22 ( 7 ): 846 – 852 . - PMC - PubMed
    1. Bazzi T , Al-Husseini M , Saravolatz L , Kafri Z . Trends in Breast Cancer Incidence and Mortality in the United States From 2004-2018: A Surveillance, Epidemiology, and End Results (SEER)-Based Study . Cureus 2023. ; 15 ( 4 ): e37982 . - PMC - PubMed

LinkOut - more resources